Singlera Genomics has entered a strategic distribution and research agreement with Pure Medical to advance non-invasive cancer detection technologies across Western Europe.

Columbia Asia Hospital Cheras in Malaysia commemorates its 15th anniversary by announcing significant facility expansions and securing the MPRA 2025 Silver Award for Best Use of Content.

Shape Memory Medical's IMPEDE Embolization Plug family achieves Class III certification under the EU's Medical Device Regulation, ensuring continued market access and reinforcing clinical confidence in peripheral vascular therapies.

Telix Pharmaceuticals reports positive top-line data from its Phase 3 study of TLX591-CDx (Illuccix) in Chinese patients with prostate cancer, enabling an upcoming NDA submission to enhance diagnostic capabilities in Asia's key market.[5]

The Philippines has introduced a Medical Concierge service at NAIA Terminal 3 in partnership with premier hospitals like The Medical City and St. Luke's, enhancing healthcare access for transit passengers and positioning the country as a medical tourism hub.

Columbia Asia Hospital Tebrau earns three prestigious awards at the 2025 Malaysia Public Relations Awards for innovative social media campaigns, community healthcare initiatives, and employee engagement strategies.

Bumrungrad International Hospital is developing a 120-bed luxury secondary care facility in Phuket, Thailand, with operations starting in mid-2027, as part of its strategic expansion[1].

NYK Group has finalized the acquisition of Walden Group's healthcare logistics business, bolstering specialized supply chain solutions for hospitals across Europe.

Columbia Asia Hospital Tebrau in Johor Bahru has outlined a multi‑year expansion strategy encompassing advanced diagnostics, robotic-assisted surgery, and additional inpatient beds to strengthen service capacity and care quality for the Johor community.

European medtech industry bodies are urging EU lawmakers to swiftly adopt proposed medical device reforms, warning that delays threaten hospital access to vital diagnostic and therapeutic technologies across Europe.